Menu

Life Sciences

Innovative Solutions for Business Leaders

In today’s complicated regulatory environment, it is more important than ever for life sciences companies to align themselves with financial professionals experienced in all aspects of the industry. We know the growing number of complex challenges your business faces - from development, to becoming a commercial organization and capitalizing on tax-efficient strategies and leveraging intellectual property. Our Life Sciences team can help guide you every step of the way.

Recommended Insight

INSIGHT ARTICLE

Improvements to employee share-based payment accounting

Learn about improvements to the share-based compensation standard and its impact on the life sciences industry.

CASE STUDY

RSM’s FAO helps support pharmaceutical company’s growth initiatives

RSM built a finance and accounting outsourcing solution to help a growing company enhance performance, reduce costs and optimize operations.

CASE STUDY

RSM helps emerging life sciences company increase financial visibility

RSM worked with InteguRX to develop a comprehensive FAO solution for more financial visibility and consistency that will scale with growth.

CASE STUDY

Corporate tax outsourcing arrangement gives client the depth it needed

Learn how RSM helped a pharmaceutical company realize better, timelier service through a tax outsourcing arrangement.

CASE STUDY

Life Sciences Company Streamlines Purchasing and Payments with NetSuite

RSM helped Moderna implement an extensive NetSuite purchasing and payment solution, with increased process automation, efficiency and accountability.

INSIGHT ARTICLE

The benefits of finance and accounting outsourcing for life sciences

Learn how growing life sciences companies leverage finance and accounting outsourcing to enhance the finance function and focus on core competencies.

WHITE PAPER

Anti-inversion legislation could affect middle market companies

While large public company inversions have received the press coverage, middle market and private companies can invert and achieve similar benefits.

CASE STUDY

Review recovers millions in royalties for life sciences company

Royalty review of three licensees discovers omitted products, unallowable deductions, unreported sales and nearly $4.5 million in underpaid royalties.

CASE STUDY

Osmotica Pharmaceutical

Michael Gesser, Vice President of Finance and Treasurer of Osmotica Pharmaceutical, discuss how their implementation of Microsoft Dynamics AX has positioned their business for future growth

CASE STUDY

RSM helps biopharmaceutical company save IPO price

With IPO on the line, RSM delivers valuation client needs to finance the future.

Contact Our Team

John Lanza
Partner,
National Practice Leader

800.274.3978
John.Lanza@rsmus.com